4//SEC Filing
Morabito Christopher 4
Accession 0001104659-25-027765
CIK 0001454789other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 4:05 PM ET
Size
5.8 KB
Accession
0001104659-25-027765
Insider Transaction Report
Form 4
Morabito Christopher
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-21+262,500→ 262,500 totalExercise: $6.41Exp: 2035-03-20→ Common Stock (262,500 underlying)
Footnotes (1)
- [F1]This option was granted on March 21, 2025 and is subject to vesting over a four-year period, with 25% of the 262,500 shares underlying the option upon grant vesting on the first anniversary of February 13, 2025 and the remainder vesting over the ensuing three years in equal monthly installments.
Documents
Issuer
Astria Therapeutics, Inc.
CIK 0001454789
Entity typeother
Related Parties
1- filerCIK 0001859284
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 4:05 PM ET
- Size
- 5.8 KB